Načítá se...
Perlecan-targeted nanoparticles for drug delivery to triple-negative breast cancer
AIM: We previously developed two antibodies that bind to a cell surface protein, perlecan, overexpressed in triple-negative breast cancer (TNBC). The goal of this study was to investigate these antibodies as targeting ligands for nanoparticle-mediated drug delivery. METHODS: Paclitaxel-loaded poly(D...
Uloženo v:
| Vydáno v: | Future Drug Discov |
|---|---|
| Hlavní autoři: | , , , , |
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
Newlands Press Ltd
2019
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6700713/ https://ncbi.nlm.nih.gov/pubmed/31448368 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4155/fdd-2019-0005 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|